Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
27.54-1.62 (-5.56%)
At close: 04:00PM EDT
27.50 -0.04 (-0.15%)
After hours: 07:13PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
-44,492
-31,292
-10,284
5,277
-6,367
Depreciation & amortisation
7,319
3,407
472
358
323.016
Deferred income taxes
-10,575
-8,736
-
-
-
Stock-based compensation
29,263
21,740
8,309
1,249
293.639
Change in working capital
-2,994
-4,102
9,148
44
-7,359
Accounts receivable
-4,984
-4,631
1,663
-896
-8,408
Inventory
-962
327
-980
-355
-577.657
Accounts payable
803
-182
169
557
197.248
Other working capital
-42,972
-22,466
5,114
6,078
-12,572
Other non-cash items
-
-
823
2,367
542.373
Net cash provided by operating activities
-39,345
-18,983
9,865
7,015
-12,295
Cash flows from investing activities
Investments in property, plant and equipment
-3,627
-3,483
-4,751
-937
-277.036
Other investing activities
-29,453
-63,184
-
-
-
Net cash used for investing activities
-59,725
-66,657
-4,748
-937
-277.036
Cash flows from financing activities
Debt repayment
-63
-8
-27,359
-1,791
0
Common stock issued
-
0
330,041
65,931
-
Other financing activities
-869
-1,117
-
-
-
Net cash used provided by (used for) financing activities
3,897
5,421
305,890
88,288
15,838
Net change in cash
-95,173
-80,219
311,007
94,366
3,266
Cash at beginning of period
368,339
409,852
98,845
4,479
1,212
Cash at end of period
273,166
329,633
409,852
98,845
4,479
Free cash flow
Operating cash flow
-39,345
-18,983
9,865
7,015
-12,295
Capital expenditure
-3,627
-3,483
-4,751
-937
-277.036
Free cash flow
-42,972
-22,466
5,114
6,078
-12,572